● Worldwide, total 12.5 million confirmed
Cases,
● 6.89 million people recovered and,
● 560 thousand people died due to
COVID-19.
Chief researcher Elena Smolyarchuk told a Russian news outlet on Sunday, July 12, Sechenov University researchers have successfully completed clinical trials of the world’s first COVID-19 vaccine on volunteers.
“The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20,” Smolyarchuk was quoted as saying in the report.
The university began clinical trials of the vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18.
According to Lukashev, further development plan for the vaccine is already determined by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production.
“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research center that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway,” Tarasov noted.
Meanwhile, the World Health Organisation had last month announced that Oxford’s vaccine was most advanced. It is expected to bed rolled out soon as AstraZeneca by Oxford is in the third phase of clinical trials.
More than a hundred vaccines against the novel coronavirus are currently under development or trials, globally. The coronavirus has infected more than 12 million people around the world, till now.
